Emerging Therapeutic Approaches for Anemia in Myelofibrosis.
- Published in:
- Current Hematologic Malignancy Reports, 2025, v. 20, n. 1, p. 1, doi. 10.1007/s11899-025-00751-4
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2025 AND VI 20 AND IP 1
Results: 7
1
2
Role of Population Based Studies in Advancing our Knowledge of Myelodysplastic Syndromes.
- Published in:
- Current Hematologic Malignancy Reports, 2025, v. 20, n. 1, p. 1, doi. 10.1007/s11899-025-00750-5
- By:
- Publication type:
- Article
3
Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL)
- Published in:
- Current Hematologic Malignancy Reports, 2025, v. 20, n. 1, p. 1, doi. 10.1007/s11899-024-00746-7
- By:
- Publication type:
- Article
4
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications.
- Published in:
- Current Hematologic Malignancy Reports, 2025, v. 20, n. 1, p. 1, doi. 10.1007/s11899-024-00749-4
- By:
- Publication type:
- Article
5
Navigating the Economic Burden of Multiple Myeloma: Insights into Cost-effectiveness of CAR-T and Bispecific Antibody Therapies.
- Published in:
- Current Hematologic Malignancy Reports, 2025, v. 20, n. 1, p. 1, doi. 10.1007/s11899-024-00748-5
- By:
- Publication type:
- Article
6
Monoclonal Gammopathy-Associated Neuropathy.
- Published in:
- Current Hematologic Malignancy Reports, 2025, v. 20, n. 1, p. 1, doi. 10.1007/s11899-024-00745-8
- By:
- Publication type:
- Article
7
Disparities in Clinical Trial Enrollment– Focus on CAR-T and Bispecific Antibody Therapies.
- Published in:
- Current Hematologic Malignancy Reports, 2025, v. 20, n. 1, p. 1, doi. 10.1007/s11899-024-00747-6
- By:
- Publication type:
- Article